Market Tracker

10/19 10:42am ET

Clovis Oncology Inc (NASDAQ:CLVS)

76.95
BATS BZX Real-Time Price
As of 10:42am ET
 -1.77 / -2.25%
Today’s Change
25.81
Today|||52-Week Range
99.45
+73.23%
Year-to-Date

Today’s Trading

Previous close78.72
Today’s open77.75
Day’s range76.77 - 77.95
Volume9,278
Average volume (3 months)1,834,617
Market cap$3.8B
Dividend yield--
Data as of 10:42am ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)+7.35%
Earnings growth (this year)+17.12%
Earnings growth (next 5 years)-84.86%
Revenue growth (last year)--
P/E ratioNM
Price/Sales21,912.70
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...-0.39-0.78%
OPKOPKO Health Inc-0.07-1.04%
PBYIPuma Biotechnology I...-2.15-1.74%
MNKMallinckrodt Plc-0.15-0.47%
Data as of 10:42am ET, 10/19/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$1.21
Annual revenue (last year)$78.0K
Annual profit (last year)-$349.1M
Net profit margin-447,611.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
Principal Financial Officer &
SVP-Finance
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts